NutriBand (NTRB) Other Working Capital Changes (2020 - 2024)
NutriBand (NTRB) posted Other Working Capital Changes of -$7207.0 for Q2 2026, down 106.36% sequentially from $113329.0 in Q1 2026, and down 9.55% YoY from -$7967.5 in Q2 2025.
NutriBand (NTRB) Other Working Capital Changes (2020 - 2024) Analysis & Trends
NutriBand has reported Other Working Capital Changes for 5 years, with the latest figure at -$7207.0 in Q2 2026.
- Quarterly Other Working Capital Changes fell 9.55% year-over-year to -$7207.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$36205.0 (up 69.84% YoY) and the FY2026 annual result came in at -$35577.0, down 2093.4% from the prior year.
- Other Working Capital Changes slipped to -$7207.0 in Q2 2026 per NTRB's latest filing, from $113329.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $174878.0 in Q4 2021 and troughed at -$133315.0 in Q1 2022.
- A 5-year average of $14184.6 and a median of $15928.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 1579.99% in 2024, down 997.09% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$12140.0 in 2022, then slumped by 298.64% to -$48395.0 in 2023, then increased by 1.88% to -$47486.0 in 2024, then soared by 73.79% to -$12445.0 in 2025, then surged by 42.09% to -$7207.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$7207.0, $113329.0, and -$12445.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 111,843.00 |
| Apr 30, 2024 | 111,843.00 |
| Apr 30, 2024 | 111,843.00 |
| Jan 31, 2024 | -11,993.00 |
| Jan 31, 2024 | -11,993.00 |
| Jan 31, 2024 | -11,993.00 |
| Oct 31, 2023 | -48,395.00 |
| Oct 31, 2023 | -48,395.00 |
| Oct 31, 2023 | -48,395.00 |
| Jul 31, 2023 | 29,193.00 |
| Jul 31, 2023 | 29,193.00 |
| Jul 31, 2023 | 29,193.00 |
| Apr 30, 2023 | 25,794.00 |
| Apr 30, 2023 | 25,794.00 |
| Apr 30, 2023 | 25,794.00 |
| Jan 31, 2023 | -39,087.00 |
| Jan 31, 2023 | -39,087.00 |
| Jan 31, 2023 | -39,087.00 |
| Oct 31, 2022 | 56,076.00 |
| Oct 31, 2022 | 56,076.00 |